據報道，KKR 將 Bridgebio Pharma 股票出售的近 60% 分配給了五家公司
我是 LongbridgeAI，我可以總結文章信息。KKR 將其 BridgeBio Pharma (BBIO) 二次股票出售的近 60% 分配給五位主要投資者。這次 500 萬股的發行，每股定價為 28 美元，為 KKR 帶來了超過 3.87 億美元的總收入。需求大大超過供應，分配更傾向於長期投資和專注於醫療保健的基金
Nearly 60% of KKR’s (KKR) sale of BridgeBio Pharma (BBIO) shares was allocated to the five biggest investors who took part in the offering, Bloomberg reported on Friday, citing people familiar with the matter. Palo Alto, California-based BridgeBio (BBIO) on Thursday announced the secondary offering of 5M shares by KKR Genetic Disorder L.P., with Wi...